Cargando…
The Dual Diverse Dynamic Reversible Effects of Ankaferd Blood Stopper on EPCR and PAI-1 Inside Vascular Endothelial Cells With and Without LPS Challenge
Objective: Ankaferd blood stopper (ABS) is comprised of a mixture of the plants Thymus vulgaris, Glycyrrhiza glabra, Vitis vinifera, Alpinia officinarum, and Urtica dioica. ABS is used as a topical hemostatic agent due to its antihemorrhagic effect, yet its hemostatic mechanism of action remains to...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781619/ https://www.ncbi.nlm.nih.gov/pubmed/24385723 http://dx.doi.org/10.5152/tjh.2011.41 |
_version_ | 1782285456060186624 |
---|---|
author | Karabıyık, Afife Yılmaz, Erkan Güleç, Şükrü Haznedaroğlu, İbrahim Akar, Nejat |
author_facet | Karabıyık, Afife Yılmaz, Erkan Güleç, Şükrü Haznedaroğlu, İbrahim Akar, Nejat |
author_sort | Karabıyık, Afife |
collection | PubMed |
description | Objective: Ankaferd blood stopper (ABS) is comprised of a mixture of the plants Thymus vulgaris, Glycyrrhiza glabra, Vitis vinifera, Alpinia officinarum, and Urtica dioica. ABS is used as a topical hemostatic agent due to its antihemorrhagic effect, yet its hemostatic mechanism of action remains to be investigated. ABS does not affect the levels of coagulation factors II, V, VII, VIII, IX, X, XI and XII. The aim of this study was to investigate the effects of ABS on endothelium and immune response. As such, we evaluated changes in endothelial cell protein C receptor (EPCR) and plasminogen activator inhibitor type-1 (PAI-1) expression inside human umbilical vein endothelial cells (HUVECs) in the presence and absence of lipopolysaccharides (LPSs). Material and Methods: We exposed HUVECs to 10 μL and 100 μL of ABS for 5 min, 25 min, 50 min, 6 h, and 24 h. Additionally, 10 μg mL–1 of LPS was administered for 1 h to observe the effects of LPS challenge on HUVECs, and then the cells were treated with ABS for 5 min, 25 min, 50 min, and 6 h to observe the effects of ABS on HUVECs. Total RNA was isolated from HUVECs and then the level of expression of EPCR and PAI-1 mRNA was measured. Results: Cells were microscopically observed to arise from the surface and adhere to each other following the administration of ABS to HUVECs. Additionally, after 24 h the cells had normal growth and physiology, which suggests that the adhesive cellular effects of ABS might be reversible. ABS had a negative effect on EPCR and PAI-1 expression; the effect in response to 100 µL was greater than that to 10 µL. EPCR and PAI-1 expression increased over time in response to LPS and 10 µL of ABS. EPCR and PAI-1 expression was very low during the first hour of exposure to LPS and 100 µL of ABS, but after 6 h increased to levels similar to those observed in response to LPS and 10 µL of ABS. Conclusion: It was observed that ABS had dual diverse dynamic reversible effects on EPCR and PAI-1 expression in HUVECs, which were dependent on dose and concentration. ABS might play a role in numerous cellular mechanisms, in addition to having hemostatic effects. Conflict of interest:None declared. |
format | Online Article Text |
id | pubmed-3781619 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Galenos Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-37816192014-01-02 The Dual Diverse Dynamic Reversible Effects of Ankaferd Blood Stopper on EPCR and PAI-1 Inside Vascular Endothelial Cells With and Without LPS Challenge Karabıyık, Afife Yılmaz, Erkan Güleç, Şükrü Haznedaroğlu, İbrahim Akar, Nejat Turk J Haematol Research Article Objective: Ankaferd blood stopper (ABS) is comprised of a mixture of the plants Thymus vulgaris, Glycyrrhiza glabra, Vitis vinifera, Alpinia officinarum, and Urtica dioica. ABS is used as a topical hemostatic agent due to its antihemorrhagic effect, yet its hemostatic mechanism of action remains to be investigated. ABS does not affect the levels of coagulation factors II, V, VII, VIII, IX, X, XI and XII. The aim of this study was to investigate the effects of ABS on endothelium and immune response. As such, we evaluated changes in endothelial cell protein C receptor (EPCR) and plasminogen activator inhibitor type-1 (PAI-1) expression inside human umbilical vein endothelial cells (HUVECs) in the presence and absence of lipopolysaccharides (LPSs). Material and Methods: We exposed HUVECs to 10 μL and 100 μL of ABS for 5 min, 25 min, 50 min, 6 h, and 24 h. Additionally, 10 μg mL–1 of LPS was administered for 1 h to observe the effects of LPS challenge on HUVECs, and then the cells were treated with ABS for 5 min, 25 min, 50 min, and 6 h to observe the effects of ABS on HUVECs. Total RNA was isolated from HUVECs and then the level of expression of EPCR and PAI-1 mRNA was measured. Results: Cells were microscopically observed to arise from the surface and adhere to each other following the administration of ABS to HUVECs. Additionally, after 24 h the cells had normal growth and physiology, which suggests that the adhesive cellular effects of ABS might be reversible. ABS had a negative effect on EPCR and PAI-1 expression; the effect in response to 100 µL was greater than that to 10 µL. EPCR and PAI-1 expression increased over time in response to LPS and 10 µL of ABS. EPCR and PAI-1 expression was very low during the first hour of exposure to LPS and 100 µL of ABS, but after 6 h increased to levels similar to those observed in response to LPS and 10 µL of ABS. Conclusion: It was observed that ABS had dual diverse dynamic reversible effects on EPCR and PAI-1 expression in HUVECs, which were dependent on dose and concentration. ABS might play a role in numerous cellular mechanisms, in addition to having hemostatic effects. Conflict of interest:None declared. Galenos Publishing 2012-12 2012-12-05 /pmc/articles/PMC3781619/ /pubmed/24385723 http://dx.doi.org/10.5152/tjh.2011.41 Text en © Turkish Journal of Hematology, Published by Galenos Publishing. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Karabıyık, Afife Yılmaz, Erkan Güleç, Şükrü Haznedaroğlu, İbrahim Akar, Nejat The Dual Diverse Dynamic Reversible Effects of Ankaferd Blood Stopper on EPCR and PAI-1 Inside Vascular Endothelial Cells With and Without LPS Challenge |
title | The Dual Diverse Dynamic Reversible Effects of Ankaferd Blood Stopper on EPCR and PAI-1 Inside Vascular Endothelial Cells With and Without LPS Challenge |
title_full | The Dual Diverse Dynamic Reversible Effects of Ankaferd Blood Stopper on EPCR and PAI-1 Inside Vascular Endothelial Cells With and Without LPS Challenge |
title_fullStr | The Dual Diverse Dynamic Reversible Effects of Ankaferd Blood Stopper on EPCR and PAI-1 Inside Vascular Endothelial Cells With and Without LPS Challenge |
title_full_unstemmed | The Dual Diverse Dynamic Reversible Effects of Ankaferd Blood Stopper on EPCR and PAI-1 Inside Vascular Endothelial Cells With and Without LPS Challenge |
title_short | The Dual Diverse Dynamic Reversible Effects of Ankaferd Blood Stopper on EPCR and PAI-1 Inside Vascular Endothelial Cells With and Without LPS Challenge |
title_sort | dual diverse dynamic reversible effects of ankaferd blood stopper on epcr and pai-1 inside vascular endothelial cells with and without lps challenge |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781619/ https://www.ncbi.nlm.nih.gov/pubmed/24385723 http://dx.doi.org/10.5152/tjh.2011.41 |
work_keys_str_mv | AT karabıyıkafife thedualdiversedynamicreversibleeffectsofankaferdbloodstopperonepcrandpai1insidevascularendothelialcellswithandwithoutlpschallenge AT yılmazerkan thedualdiversedynamicreversibleeffectsofankaferdbloodstopperonepcrandpai1insidevascularendothelialcellswithandwithoutlpschallenge AT gulecsukru thedualdiversedynamicreversibleeffectsofankaferdbloodstopperonepcrandpai1insidevascularendothelialcellswithandwithoutlpschallenge AT haznedarogluibrahim thedualdiversedynamicreversibleeffectsofankaferdbloodstopperonepcrandpai1insidevascularendothelialcellswithandwithoutlpschallenge AT akarnejat thedualdiversedynamicreversibleeffectsofankaferdbloodstopperonepcrandpai1insidevascularendothelialcellswithandwithoutlpschallenge AT karabıyıkafife dualdiversedynamicreversibleeffectsofankaferdbloodstopperonepcrandpai1insidevascularendothelialcellswithandwithoutlpschallenge AT yılmazerkan dualdiversedynamicreversibleeffectsofankaferdbloodstopperonepcrandpai1insidevascularendothelialcellswithandwithoutlpschallenge AT gulecsukru dualdiversedynamicreversibleeffectsofankaferdbloodstopperonepcrandpai1insidevascularendothelialcellswithandwithoutlpschallenge AT haznedarogluibrahim dualdiversedynamicreversibleeffectsofankaferdbloodstopperonepcrandpai1insidevascularendothelialcellswithandwithoutlpschallenge AT akarnejat dualdiversedynamicreversibleeffectsofankaferdbloodstopperonepcrandpai1insidevascularendothelialcellswithandwithoutlpschallenge |